207_Combined course Presentations

First page Table of contents Previous page 991 Next page Last page

Cisplatin + Etoposide vs Carboplatin + Paclitaxel : NO OS DIFFERENCE but INCREASE TOXICITY wit Cisplatin + Etoposide

OS after propensity score

OS in Overall Population

Patients treated with Cisplatin + Etoposide had:  More hospitalizations (p <0.001)  Infectious complications (p = 0.002)  Acute kidney disease (p < 0.001)  Mucositis/esophagitis (p = 0.02)

Santana-Davila R, et al, JCO, 2015;33

Made with